SDGR
NASDAQ HealthcareSchrodinger, Inc. - Common Stock
Health Information Services
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
�� 市场数据
| 价格 | $12.34 |
|---|---|
| 成交量 | 2,496,346 |
| 市值 | 911.00M |
| 贝塔系数 | 1.620 |
| RSI（14日） | 74.2 超买 |
| 200日均线 | $17.31 |
| 50日均线 | $12.05 |
| 52周最高 | $27.63 |
| 52周最低 | $10.95 |
| Forward P/E | -8.94 |
| Price / Book | 2.50 |
🎯 投资策略评分
SDGR 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (89/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 💰 Dividend Daddy (12/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 SDGR in your text
粘贴任何文章、记录或帖子 — 工具将提取 SDGR 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.